Close Menu

NEW YORK (GenomeWeb) – Multi-gene panel testing can identify patients who are carriers of pathogenic variants who might otherwise be missed under current genetic testing guidelines, according to a new study from Color researchers.

Current guidelines, such as the ones from the National Comprehensive Cancer Network (NCCN), recommend genetic testing for people who have a personal or family history of cancer that indicates they might be at an increased risk of harboring a pathogenic familial variant. But this approach could miss people who lack any personal or family history.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Jul
23

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.